本文へ移動
cccskills
無料GitHub で公開

es-monitor-prolactin-transgender-female

This skill indicates the need for periodic prolactin monitoring in transgender females undergoing estrogen therapy. Clinical triggers include a transgender female patient receiving estrogen treatment.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.5 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Monitor prolactin levels in transgender females on estrogen

STEP 1 — Gather Information

Collect baseline prolactin, estradiol, and testosterone levels; assess for symptoms of hyperprolactinemia (galactorrhea, headache, visual changes); review current estrogen dose and type, and concomitant medications (e.g., spironolactone, antipsychotics) that may affect prolactin.

STEP 2 — Rule In / Rule Out

If prolactin exceeds the upper limit of normal (lab-specific, e.g., >20 ng/mL), proceed to evaluate for prolactinoma; otherwise, continue routine monitoring per schedule.

STEP 3 — Classify or Stratify

If prolactin is elevated, assess symptom severity and consider pituitary imaging; if prolactin remains within normal limits, maintain scheduled monitoring.

STEP 4 — Decide

If MRI reveals a pituitary lesion, refer to endocrinology or neurosurgery and consider dose reduction of estrogen or adding cabergoline; if no lesion and prolactin is mildly elevated (<2× ULN), repeat prolactin in 3 months; if normal, repeat prolactin annually for the first year then every 2 years thereafter.

Clinical Guardrails / Mimics / Pitfalls

Do not discontinue estrogen solely for asymptomatic mild prolactin elevation without evaluation; do not mistake macroprolactin for true hyperprolactinemia (consider polyethylene glycol precipitation test if discrepancy); do not overlook medication‑induced prolactin rise (e.g., antipsychotics, anti‑emetics); do not delay imaging in symptomatic patients with markedly elevated prolactin (>5× ULN) or visual field defects.

Concrete Clinical Example

A 22‑year‑old transgender female on estradiol 4 mg daily and spironolactone 100 mg daily presents for routine follow‑up. Baseline prolactin was 12 ng/mL. At 12‑month visit, prolactin is 38 ng/mL (ULN 20 ng/mL). She denies galactorrhea or headaches; estradiol is 150 pg/mL, testosterone <50 ng/dL. Prolactin is moderately elevated without symptoms, so repeat prolactin in 3 months; if persistent, order pituitary MRI.

Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, Wylie C. Hembree et al., Endocrine Society, 2017, doi:10.1210/jc.2017-01658

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する